Deutsche bank rated ISIS a buy here under one of the reason :
According to Deutsche, ISIS' risk/reward trade-off remains particularly attractive. "ISIS is a leading platform biotech company with a technology that can silence genes called antisense. We think the platform has significantly evolved and is validated," noted Young.
....and for ANP antisense is what is all about
deutsche bank
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $2.723K | 25.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 97055 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 116599 | 2 |
View Market Depth
| Last trade - 10.14am 08/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |